Relationship between the frequency of blood pressure self-measurement and blood pressure reduction with antihypertensive therapy: Results of the OLMETEL (OLMEsartan TELemonitoring blood pressure) study

Clinical Drug Investigation

Volumn 26, Issue 8, 2006, Pages 439-446

  Ewald, Silke ^a   Vor Dem Esche, Johannes ^b   Uen, Sakir ^c   Neikes, Fabian ^c   Vetter, Hans ^c   Mengden, Thomas ^c  

^a Sankyo Pharma GmbH   (Germany)

^b TeleMed Project GmbH   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OLMESARTAN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLE; DISEASE DURATION; DRUG USE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF MONITORING; SENSITIVITY AND SPECIFICITY; SYSTOLE; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; REPRODUCIBILITY OF RESULTS; TELEMEDICINE; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME;

EID: 33747211034     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200626080-00002     Document Type: Article

References (28)

1. Chalmers J, MacMahon S, Mancia G, et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines Subcommittee of the World Health Organization. Clin Exp Hypertens 1999; 21 (5-6): 1009-60
2. O'Brien E, Beevers G, Lip GY. ABC of hypertension: blood pressure measurement. Part IV-automated sphygmomanometry: self blood pressure measurement. BMJ 2001; 322 (7295): 1167-70
3. O'Brien E, Fitzgerald D. The history of blood pressure measurement. J Hum Hypertens 1994; 8 (2): 73-84
4. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21 (5): 821-48
5. Denolle T, Waeber B, Kjeldsen S, et al. Self-measurement of blood pressure in clinical trials and therapeutic applications. Blood Press Monit 2000; 5 (2): 145-9
6. Imai Y, Ohkubo T, Hozawa A, et al. Usefulness of home blood pressure measurements in assessing the effect of treatment in a single-blind placebo-controlled open trial. J Hypertens 2001; 19 (2): 179-85
7. Brueren MM, Schouten HJ, de Leeuw PW, et al. A series of self-measurements by the patient is a reliable alternative to ambulatory blood pressure measurement. Br J Gen Pract 1998; 48 (434): 1585-9
8. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328 (7440): 634-40
9. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289 (19): 2560-72
10. Ball KJ, Williams PA, Stumpe KO. Relative efficacy of an angiotensin II antagonist compared with other antihypertensive agents: olmesartan medoxomil versus antihypertensives. J Hypertens Suppl 2001; 19 Suppl. 1: S49-56
11. Chrysant SG, Marbury TC, Robinson TD. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension. J Hum Hypertens 2003; 17 (6): 425-32
12. Chilman-Blair K, Rabasseda X. Olmesartan, an AT1-selective antihypertensive agent. Drugs Today (Barc) 2003; 39 (10): 745-61
13. Stumpe KO, Ludwig M. Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs. J Hum Hypertens 2002; 16 Suppl. 2: S24-8
14. Warner GT, Jarvis B. Olmesartan medoxomil. Drugs 2002; 62 (9): 1345-53
15. Mengden T, Ewald S, Kaufmann S, et al. Telemonitoring of blood pressure self measurement in the OLMETEL study. Blood Press Monit 2004; 9 (6): 321-5
16. Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). [Recommendations for design, conduct and evaluation of post-marketing surveillance studies]. BfArM, Bundesanzeiger [Federal Gazette] No. 229; 04 Dec 1998
17. European Parliament and Council. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to medicinal products for human use, 2004
18. Illyes M, Mengden T, Tisler A. The virtual hypertension clinic. Blood Press Monit 2002; 7 (1): 67-8
19. Mengden T, Chamontin B, Phong Chau N, et al. User procedure for self-measurement of blood pressure. First International Consensus Conference on Self Blood Pressure Measurement. Blood Press Monit 2000; 5 (2): 111-29
20. Ashida T, Sugiyama T, Okuno S, et al. Relationship between home blood pressure measurement and medication compliance and name recognition of antihypertensive drugs. Hypertens Res 2000; 23 (1): 21-4
21. Chatellier G, Dutrey-Dupagne C, Vaur L, et al. Home self blood pressure measurement in general practice. The SMART study. Self-measurement for the Assessment of the Response to Trandolapril. Am J Hypertens 1996; 9 (7): 644-52
22. Kantola I, Halme L, Kaaja M, et al. Intermittent self-monitoring of blood pressure at home decreases blood pressure and promotes the achievement of the target pressure in primary care setting [abstract]. J Hypertens 2005; 23 Suppl. 2: S32
23. Rogers MA, Small D, Buchan DA, et al. Home monitoring service improves mean arterial pressure in patients with essential hypertension: a randomized, controlled trial. Ann Intern Med 2001; 134 (11): 1024-32
24. Mengden T, Vetter H, Tisler A, et al. Tele-monitoring of home blood pressure. Blood Press Monit 2001; 6 (4): 185-9
25. Gerin W, Holland J, Glenn J, et al. Telephone-linked home blood pressure monitoring in the management of hypertension [abstract]. Circulation 1998; 98 Suppl. 1: 324
26. Mengden T, Uen S, Baulmann J, et al. Significance of blood pressure self-measurement as compared with office blood pressure measurement and ambulatory 24-hour blood pressure measurement in pharmacological studies. Blood Press Monit 2003; 8 (4): 169-72
27. Mengden T, Baettig B, Vetter W. Self-measurement of blood pressure improves the accuracy and reduces the number of subjects in clinical trials. J Hypertens Suppl 1991; 9 (6): S336-7
28. Ragot S, Genes N, Vaur L, et al. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response. Am J Hypertens 2000; 13 (6 Pt 1): 632-9